64 related articles for article (PubMed ID: 21168392)
21. Substance P induces inward current and regulates pacemaker currents through tachykinin NK1 receptor in cultured interstitial cells of Cajal of murine small intestine.
Jun JY; Choi S; Yeum CH; Chang IY; You HJ; Park CK; Kim MY; Kong ID; Kim MJ; Lee KP; So I; Kim KW
Eur J Pharmacol; 2004 Jul; 495(1):35-42. PubMed ID: 15219818
[TBL] [Abstract][Full Text] [Related]
22. Point mutation increases a form of the NK1 receptor with high affinity for neurokinin A and B and septide.
Ciucci A; Palma C; Manzini S; Werge TM
Br J Pharmacol; 1998 Sep; 125(2):393-401. PubMed ID: 9786514
[TBL] [Abstract][Full Text] [Related]
23. MEN15596, a novel nonpeptide tachykinin NK2 receptor antagonist.
Cialdai C; Tramontana M; Patacchini R; Lecci A; Catalani C; Catalioto RM; Meini S; Valenti C; Altamura M; Giuliani S; Maggi CA
Eur J Pharmacol; 2006 Nov; 549(1-3):140-8. PubMed ID: 16979621
[TBL] [Abstract][Full Text] [Related]
24. Neurokinin-1 receptor mediated breast cancer cell migration by increased expression of MMP-2 and MMP-14.
Li J; Zeng Q; Zhang Y; Li X; Hu H; Miao X; Yang W; Zhang W; Song X; Mou L; Wang R
Eur J Cell Biol; 2016 Oct; 95(10):368-377. PubMed ID: 27498853
[TBL] [Abstract][Full Text] [Related]
25. Activation of BNGR-A24 by direct interaction with tachykinin-related peptides from the silkworm Bombyx mori leads to the Gq- and Gs-coupled signaling cascades.
He X; Zang J; Li X; Shao J; Yang H; Yang J; Huang H; Chen L; Shi L; Zhu C; Zhang G; Zhou N
Biochemistry; 2014 Oct; 53(42):6667-78. PubMed ID: 25275886
[TBL] [Abstract][Full Text] [Related]
26. Tachykinin peptide-induced activation and desensitization of neurokinin 1 receptors.
Perrine SA; Bennett VJ; Simmons MA
Peptides; 2003 Mar; 24(3):469-75. PubMed ID: 12732347
[TBL] [Abstract][Full Text] [Related]
27. The tachykinin NK1 receptor. Part I: ligands and mechanisms of cellular activation.
Quartara L; Maggi CA
Neuropeptides; 1997 Dec; 31(6):537-63. PubMed ID: 9574822
[TBL] [Abstract][Full Text] [Related]
28. Expression and function of human hemokinin-1 in human and guinea pig airways.
Grassin-Delyle S; Naline E; Buenestado A; Risse PA; Sage E; Advenier C; Devillier P
Respir Res; 2010 Oct; 11(1):139. PubMed ID: 20929541
[TBL] [Abstract][Full Text] [Related]
29. Membrane-induced structure of novel human tachykinin hemokinin-1 (hHK1).
Ganjiwale A; Cowsik SM
Biopolymers; 2015 Dec; 103(12):702-10. PubMed ID: 26297926
[TBL] [Abstract][Full Text] [Related]
30. Structure-activity relationship study of tachykinin peptides for the development of novel neurokinin-3 receptor selective agonists.
Misu R; Noguchi T; Ohno H; Oishi S; Fujii N
Bioorg Med Chem; 2013 Apr; 21(8):2413-2417. PubMed ID: 23473945
[TBL] [Abstract][Full Text] [Related]
31. Functional analysis of synthetic insectatachykinin analogs on recombinant neurokinin receptor expressing cell lines.
Torfs H; Akerman KE; Nachman RJ; Oonk HB; Detheux M; Poels J; Loy TV; Loof AD; Meloen RH; Vassart G; Parmentier M; Broeck JV
Peptides; 2002 Nov; 23(11):1999-2005. PubMed ID: 12431738
[TBL] [Abstract][Full Text] [Related]
32. Desensitization of the neurokinin 1 receptor is mediated by the receptor carboxy-terminal region, but is not caused by receptor internalization.
Sanders MA; LeVine H
J Neurochem; 1996 Dec; 67(6):2362-72. PubMed ID: 8931468
[TBL] [Abstract][Full Text] [Related]
33. Mass spectrometric studies on the peptide integrity of substance P and related human tachykinins in human biofluids.
Feickert M; Burckhardt BB
Peptides; 2021 Feb; 136():170458. PubMed ID: 33248147
[TBL] [Abstract][Full Text] [Related]
34. Newly discovered tachykinins raise new questions about their peripheral roles and the tachykinin nomenclature.
Patacchini R; Lecci A; Holzer P; Maggi CA
Trends Pharmacol Sci; 2004 Jan; 25(1):1-3. PubMed ID: 14723970
[TBL] [Abstract][Full Text] [Related]
35. [Particularities of Spatial Organization of Human Hemokinin-1 and Mouse/Rat Hemokinin-1 Molecules].
Agaeva GA; Agaeva UT; Godjaev NM
Biofizika; 2015; 60(3):457-70. PubMed ID: 26349209
[TBL] [Abstract][Full Text] [Related]
36. Mouse Hemokinin-1 Decapeptide Subjected to a Brain-specific Post-translational Modification.
Deliconstantinos G; Barton S; Soloviev M; Page N
In Vivo; 2017; 31(5):991-998. PubMed ID: 28882971
[TBL] [Abstract][Full Text] [Related]
37. Development of Neuropeptide Hemokinin-1 Analogues with Antimicrobial and Wound-Healing Activity.
Yao Y; Zhang W; Li S; Xie H; Zhang Z; Jia B; Huang S; Li W; Ma L; Gao Y; Song J; Wang R
J Med Chem; 2023 May; 66(10):6617-6630. PubMed ID: 36893465
[TBL] [Abstract][Full Text] [Related]
38. The role of substance P, hemokinin and their receptor in governing mucosal inflammation and granulomatous responses.
Weinstock JV
Front Biosci; 2004 May; 9():1936-43. PubMed ID: 14977599
[TBL] [Abstract][Full Text] [Related]
39. Validated mass spectrometric assay for the quantification of substance P and human hemokinin-1 in plasma samples: A design of experiments concept for comprehensive method development.
Feickert M; Burckhardt BB
J Pharm Biomed Anal; 2020 Nov; 191():113542. PubMed ID: 32871415
[TBL] [Abstract][Full Text] [Related]
40. Skin codelivery of contact sensitizers and neurokinin-1 receptor antagonists integrated in microneedle arrays suppresses allergic contact dermatitis.
Bandyopadhyay M; Morelli AE; Balmert SC; Ward NL; Erdos G; Sumpter TL; Korkmaz E; Kaplan DH; Oberbarnscheidt MH; Tkacheva O; Shufesky WJ; Falo LD; Larregina AT
J Allergy Clin Immunol; 2022 Jul; 150(1):114-130. PubMed ID: 35085664
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
